Use of CAR-T Cell Therapy to Target Solid Tumors
CAR-T cell therapy has had success in treating children and adults with leukemia and lymphoma. However, CAR T cells have not had the same success against solid tumors.
Immuneel Therapeutics raises $15M and starts patient trials for CAR-T cancer therapies
Indian biotech start-up Immuneel Therapeutics has announced it has started patient dosing in a CAR-T trial named “IMAGINE.”
Synthetic CAR Libraries May Aid Immunotherapy Development
Over the past decade, substantial progress has been made in modern immunotherapy, driven by targeted therapies that inhibit tumor angiogenesis and intrinsic drivers of cancer-cell growth.
New way forward for gene therapy
A team of scientists from Children's Medical Research Institute (CMRI) in Sydney have developed a new way to improve targeting of specific organs and tissue types in gene therapy—making this innovative gene delivery technology more efficient and described as having "massive potential" for the field.
